Britain to Continue Use of Thimerosal
January 15, 2003
Britain's Department of Health announced Tuesday that it will continue to use thimerosal-based vaccines in children despite reports that the mercury-based preservative may harm infants. Designed to prevent microbial contamination, thimerosal has been used in vaccines for over 60 years, but recent reports have linked the substance to the development of autism in infants.
Britain's Committee on the Safety of Medicines and the U.S. Institute of Medicine, however, have reportedly found "no evidence of any effect of low doses of thimerosal on childhood development." The Joint Committee on Vaccination and Immunisation told Britain's Department of Health that alternative vaccines without thimerosal were less effective and may fail to protect children properly against disease.
-- Article Courtesy of InjuryBoard.com
More ...
- Thimerosal Case to be Heard in State Court
- RhoGAM
- Connection Between Thimerosal and Developmental Disorders 'Biologically Plausible'
.